Cargando…
Serological Correlate of Protection in Guinea Pigs for a Recombinant Protective Antigen Anthrax Vaccine Produced from Bacillus brevis
OBJECTIVE: Recombinant protective antigen (rPA) is the active pharmaceutical ingredient of a second generation anthrax vaccine undergoing clinical trials both in Korea and the USA. By using the rPA produced from Bacillus brevis pNU212 expression system, correlations of serological immune response to...
Autores principales: | Chun, Jeong-Hoon, Choi, On-Jee, Cho, Min-Hee, Hong, Kee-Jong, Seong, Won Keun, Oh, Hee-Bok, Rhie, Gi-Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Centers for Disease Control and Prevention
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738701/ https://www.ncbi.nlm.nih.gov/pubmed/24159510 http://dx.doi.org/10.1016/j.phrp.2012.07.006 |
Ejemplares similares
-
A mutated recombinant subunit vaccine protects mice and guinea pigs against botulinum type A intoxication
por: Yu, Chi Ho, et al.
Publicado: (2017) -
A putative exosporium lipoprotein GBAA0190 of Bacillus anthracis as a potential anthrax vaccine candidate
por: Jeon, Jun Ho, et al.
Publicado: (2021) -
Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection
por: Reed, Matthew D., et al.
Publicado: (2015) -
Human Anthrax Vaccine Development in Korea National Institute of Health
por: Rhie, Gi-eun
Publicado: (2011) -
Anthrax, but Not Bacillus anthracis?
por: Okinaka, Richard, et al.
Publicado: (2006)